Inhibition of protein kinase (PK) Cδ attenuates methamphetamine-induced dopaminergic toxicity via upregulation of phosphorylation of tyrosine hydroxylase at Ser40 by modulation of protein phosphatase 2A and PKA

被引:14
作者
Duy-Khanh Dang [1 ]
Duong, Chu X. [1 ,2 ]
Nam, Yunsung [1 ]
Shin, Eun-Joo [1 ]
Lim, Yong Kwang [1 ]
Jeong, Ji Hoon [3 ]
Jang, Choon-Gon [4 ]
Nah, Seung-Yeol [5 ,6 ]
Nabeshima, Toshitaka [7 ]
Kim, Hyoung-Chun [1 ]
机构
[1] Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon 200701, South Korea
[2] Cantho Univ Med & Pharm, Cantho City, Vietnam
[3] Chung Ang Univ, Coll Med, Dept Pharmacol, Seoul 156756, South Korea
[4] Sungkyunkwan Univ, Sch Pharm, Dept Pharmacol, Suwon, South Korea
[5] Konkuk Univ, Dept Physiol, Ginseng Res Lab, Coll Vet Med, Seoul, South Korea
[6] Konkuk Univ, Bio Mol Informat Ctr, Seoul, South Korea
[7] Meijo Univ, Grad Sch Pharmaceut Sci, Dept Chem Pharmacol, Nagoya, Aichi, Japan
关键词
dopaminergic toxicity; methamphetamine; phosphorylated tyrosine hydroxylase; PKC; -mice; protein kinase A; protein kinase C; protein phosphatase 2A; striatum; SIGNALING PATHWAYS; MAP-KINASE; IN-VIVO; ACTIVATION; STRESS; GENE; ROTTLERIN; CELLS; IDENTIFICATION; TRANSCRIPTION;
D O I
10.1111/1440-1681.12341
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recently, we proposed that inhibition of protein kinase (PK) C may be a useful target for protection against methamphetamine (MA)-induced dopaminergic toxicity. We demonstrated that treatment with MA resulted in a significant decrease in phosphorylation of tyrosine hydroxylase (TH) at Ser(40) in the striatum, but not in the phosphorylation of TH at Ser(31). In the present study, treatment with rottlerin (1.5 or 3.0 g, i.c.v, once a day for 5 days), a PKC inhibitor, or a PKC antisense oligonucleotide (ASO; 2.5 g/l, i.c.v., 3 times) significantly attenuated MA-induced reductions in the phosphorylation of TH at Ser(40) and in the expression of PKA in the striatum of mice. This attenuation was significantly counteracted by H89 (10 or 30 ng, i.c.v., 1 h after the last MA administration), a PKA inhibitor. Treatment with rottlerin or ASO significantly attenuated the MA-induced increase in protein phosphatase (PP) 2A activity. FTY720 (1 or 5 mg/kg, i.p., 1 h after the last MA administration), a PP2A activator, significantly reversed the recovery in TH phosphorylation mediated by inhibition of PKC after MA treatment. Both H89 and FTY720 counteracted the recovery of MA-induced behavioural impairments induced by PKC inhibition. The effects, mediated by rottlerin or ASO in MA-treated wild-type mice were comparable with those in MA-treated PKC-/- mice. However, neither inhibition of the mitogen-activated protein kinase subfamily (extracellular signal-regulated kinase, c-Jun N-terminal kinase, p38) nor inhibition of calcium calmodulin kinase II significantly altered PKC inhibition-mediated attenuation of MA-induced impairment of TH phosphorylation. The results suggest that genetic or pharmacological inhibition of PKC requires modulation of PKA expression and/or PP2A activity to attenuate the impairment of TH phosphorylation at Ser(40) and behavioural activity induced by MA.
引用
收藏
页码:192 / 201
页数:10
相关论文
共 49 条
  • [1] A Rare Novel Deletion of the Tyrosine Hydroxylase Gene in Parkinson Disease
    Bademci, Gueney
    Edwards, Todd L.
    Torres, Andre L.
    Scott, William K.
    Zuechner, Stephan
    Martin, Eden R.
    Vance, Jeffery M.
    Wang, Liyong
    [J]. HUMAN MUTATION, 2010, 31 (10) : E1767 - E1771
  • [2] Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
    Bonni, A
    Brunet, A
    West, AE
    Datta, SR
    Takasu, MA
    Greenberg, ME
    [J]. SCIENCE, 1999, 286 (5443) : 1358 - 1362
  • [3] Stress-induced p38 mitogen-activated protein kinase activation mediates κ-opioid-dependent dysphoria
    Bruchas, Michael R.
    Land, Benjamin B.
    Aita, Megumi
    Xu, Mei
    Barot, Sabiha K.
    Li, Shuang
    Chavkin, Charles
    [J]. JOURNAL OF NEUROSCIENCE, 2007, 27 (43) : 11614 - 11623
  • [4] CAMPBELL DG, 1986, J BIOL CHEM, V261, P489
  • [5] Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress
    Cavanaugh, Jane E.
    Jaumotte, Juliann D.
    Lakoski, Joan M.
    Zigmond, Michael J.
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2006, 84 (06) : 1367 - 1375
  • [6] Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells
    Chalovich, Elisabeth M.
    Zhu, Jian-Hui
    Caltagarone, John
    Bowser, Robert
    Chu, Charleen T.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (26) : 17870 - 17881
  • [7] The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia
    Czech, Bozena
    Pfeilschifter, Waltraud
    Mazaheri-Omrani, Niloufar
    Strobel, Marc Andre
    Kahles, Timo
    Neumann-Haefelin, Tobias
    Rami, Abdelhaq
    Huwiler, Andrea
    Pfeilschifter, Josef
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 389 (02) : 251 - 256
  • [8] Specificity and mechanism of action of some commonly used protein kinase inhibitors
    Davies, SP
    Reddy, H
    Caivano, M
    Cohen, P
    [J]. BIOCHEMICAL JOURNAL, 2000, 351 (351) : 95 - 105
  • [9] Signalling pathways underlying neural cell adhesion molecule-mediated survival of dopaminergic neurons
    Ditlevsen, Dorte Kornerup
    Berezin, Vladimir
    Bock, Elisabeth
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2007, 25 (06) : 1678 - 1684
  • [10] Tyrosine hydroxylase phosphorylation: regulation and consequences
    Dunkley, PR
    Bobrovskaya, L
    Graham, ME
    von Nagy-Felsobuki, EI
    Dickson, PW
    [J]. JOURNAL OF NEUROCHEMISTRY, 2004, 91 (05) : 1025 - 1043